• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
ATH
Click for more information
10.0% 1.1¢

ALTERITY THERAPEUTICS LIMITED

Market Cap $60.40M  ! watchlist Created with Sketch. Add to my watchlist
Healthcare Biotechnology

Alterity Therapeutics Limited is an Australia-based clinical-stage biotechnology company.... Alterity Therapeutics Limited is an Australia-based clinical-stage biotechnology company. The Company is focused on developing disease modifying treatments for neurodegenerative diseases. The Company's lead asset, ATH434, is to treat various Parkinsonian disorders. ATH434 is an oral agent designed to inhibit the aggregation of pathological proteins implicated in neurodegeneration. It has the potential to treat Parkinson's disease, as well as various Parkinsonian disorders, such as Multiple System Atrophy (MSA). The Company also has a drug discovery platform generating patentable chemical compounds to intercede in disease processes. ATH434 has been granted Orphan designation for the treatment of MSA. The Phase II clinical trial is a randomized, double-blind, placebo-controlled investigation of ATH434 in patients with early-stage MSA.More

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
ATH
Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy
5 6 7
15/02/25 394 105K
15/02/25 Last post  Jimbob77 Comments Created with Sketch.  394  Views Created with Sketch.  105K 
ATH
553,461 shorted shares in NY 		14/02/25 7 2.0K
14/02/25 Last post  Kyriaco Comments Created with Sketch.  7  Views Created with Sketch.  2.0K 
ATH
Stock price - ATH/ATHE
17 18 19
14/02/25 1.1K 333K
TRENDING NEWS

HotCopper is Now on YouTube!

Watch Now right-arrow Created with Sketch.
NEWS
15 Feb 2025
14/02/25 Last post  groins Comments Created with Sketch.  1.1K  Views Created with Sketch.  333K 
ATH
Greatest risk of AD is poor control of ferroptosis 		13/02/25 17 5.8K
13/02/25 Last post  pivalde Comments Created with Sketch.  17  Views Created with Sketch.  5.8K 
ATH
Brain Fe / cognition / ch. kidney patients 		12/02/25 1 617
12/02/25 Last post  bj31 Comments Created with Sketch.  1  Views Created with Sketch.  617 
ATH
Ann: Change in substantial holding
2
12/02/25 63 19K
12/02/25 Last post  Tradeyoursoul Comments Created with Sketch.  63  Views Created with Sketch.  19K 
ATH
Ann: Alterity raises A$40m to Advance ATH434 Development in MSA
2
11/02/25 73 19K
11/02/25 Last post  Jasper22 Comments Created with Sketch.  73  Views Created with Sketch.  19K 
ATH
Lundbeck P3 for Lu AB82422 has started 		11/02/25 2 974
11/02/25 Last post  skint Comments Created with Sketch.  2  Views Created with Sketch.  974 

See All Discussions arrow Created with Sketch.

Timeline

Proposed issue of securities - ATH
10 Feb 10:25
 
Alterity raises A$40m to Advance ATH434 Development in MSA
10 Feb 10:23
 
Ceasing to be a substantial holder
07 Feb 08:21
 
Trading Halt
06 Feb 08:55
 
Becoming a substantial holder
06 Feb 08:20
 
Disclosure under Takeovers Panel GN 20
05 Feb 14:14
 
View More arrow Created with Sketch.

Featured News

NEWS Sunrise Energy Metals Extends Aluminium-Scandium Research Partnership with UACJ Corporation
right-arrow Created with Sketch.
NEWS First Gold Extracted from Bulk Sampling at Revere Gold Project
right-arrow Created with Sketch.
NEWS High-Grade Gold Intersections at Kurundi and New Regional Discoveries in 2024 Assay Update
right-arrow Created with Sketch.
NEWS Scorpion Minerals to Farm Into E79 Gold's Jungar Flats Project in Western Australia
right-arrow Created with Sketch.
NEWS Maiden Mineral Resource Estimate and Metallurgical Testing Set to Begin at Caladao Project
right-arrow Created with Sketch.
NEWS HotCopper is Now on YouTube!
right-arrow Created with Sketch.
(20min delay)
Last
1.1¢ 		Change
0.001(10.0%) 		Mkt cap ! $60.40M
Open High Low Value Volume
1.1¢ 1.1¢ 1.1¢ $88.73K 8.096M

Buyers (Bids)

No. Vol. Price($)
61 35562828 1.0¢
 

Sellers (Offers)

Price($) Vol. No.
1.1¢ 11188786 8
View Market Depth
Last trade - 16.10pm 14/02/2025 (20 minute delay) ?
ATH (ASX) Chart

Top Stories

'Wish them good luck': Olympio sells out of Halls Creek gold play

Olympio Metals is selling its three east Kimberley gold tenements to focus on drilling at its copper and gold project in Quebec.
Cochlear shareholders hear 8% higher dividend Cochlear will pay an 8% higher dividend; profits were up 7% for the half year to the end of 2024 despite falling services revenue.
AMP records 'solid year of growth' with 15% profit rise AMP Ltd said its underlying NPAT for the 2024 fiscal year had come in 15.1% higher, based on solid performances in wealth businesses
South32 in the spotlight as US tariff talks heat up The Oz aluminium industry stands at a crossroads as the U.S. flirts with sweeping tariffs on imports, putting South32 in the spotlight.
Scorpion jumps 80% after JV sees it gain major foothold in WA gold territory Scorpion Minerals Ltd has seen its share price rise more than 73% on news of a joint venture in the WA Murchison

Featured News

MGU Local Ore Supply Strategy Reevaluated by Magnum in Response to U.S. Tariffs
right-arrow Created with Sketch.
NEWS HotCopper is Now on YouTube!
right-arrow Created with Sketch.
NEWS Sunrise Energy Metals Extends Aluminium-Scandium Research Partnership with UACJ Corporation
right-arrow Created with Sketch.
NEWS Strategic Acquisition of High-Grade Apollo Gold Project in Victoria by Adelong Gold
right-arrow Created with Sketch.
NEWS First Gold Extracted from Bulk Sampling at Revere Gold Project
right-arrow Created with Sketch.
NEWS High-Grade Gold Intersections at Kurundi and New Regional Discoveries in 2024 Assay Update
right-arrow Created with Sketch.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.